Effect of dietary stanolesters on hepatic lipid metabolism in APOE*3-Leiden transgenic mice

被引：0
|
作者：
Volger, OL
van der Boom, J
de Wit, ECM
van Duyvenvoorde, W
Hornstra, G
Plat, J
Havekes, LM
Princen, HMG
Mensink, RP
机构：
[1] TNO, Gaubius Lab, PG, NL-2301 CE Leiden, Netherlands
[2] Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Netherlands
来源：
ATHEROSCLEROSIS | 1999年 / 144卷
关键词：
D O I：
10.1016/S0021-9150(99)80366-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] The metabolism of VLDL remnants in ApoE*3-Leiden transgenic mice
    Havekes, LM
    vanVlijmen, BJM
    Jong, MC
    Groot, PHE
    Frants, RR
    Hofker, MH
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 263 - 270
  • [2] Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice
    Santo, SMSE
    van Vlijmen, BJM
    van Duyvenvoorde, W
    Offerman, EH
    Havekes, LM
    Arnault, I
    Auger, J
    Princen, HMG
    ATHEROSCLEROSIS, 2004, 177 (02) : 291 - 297
  • [3] Compensatory enlargement and stenosis develop in ApoE-/- and ApoE*3-Leiden transgenic mice
    Lutgens, E
    de Muinck, ED
    Heeneman, S
    Daemen, MJAP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) : 1359 - 1365
  • [4] Atherosclerosis in APOE*3-Leiden transgenic mice - From proliferative to atheromatous stage
    Lutgens, E
    Daemen, M
    Kockx, M
    Doevendans, P
    Hofker, M
    Havekes, L
    Wellens, H
    de Muinck, ED
    CIRCULATION, 1999, 99 (02) : 276 - 283
  • [5] Effects of dietary fatty acids on lipoprotein metabolism and changes in hepatic protein levels in apolipoprotein E*3-Leiden transgenic mice
    De Roos, B
    Duivenvoorden, I
    Teusink, B
    Pickard, K
    Havekes, LM
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 279 - 280
  • [6] APOE*2(158) transgenic mice develop a more severe hyperlipoproteinemic phenotype than APOE*3-Leiden transgenic mice
    vanVlijmen, BJ
    vanDijk, KW
    vantHof, BH
    vanGorp, PJ
    vanderBoom, H
    Holker, MH
    Havekes, LM
    CIRCULATION, 1996, 94 (08) : 3032 - 3032
  • [7] Ritonavir causes hypertriglyceridaemia in APOE*3-Leiden transgenic mice by impairing triglyceride clearance
    den Boer, M
    Berbée, JFP
    Rensen, PCN
    Romijn, JA
    Reiss, P
    van der Valk, M
    Voshol, PJ
    Havekes, LM
    ANTIVIRAL THERAPY, 2004, 9 (06) : L13 - L13
  • [8] Integrative biological analysis of the APOE*3-Leiden transgenic mouse
    Clish, CB
    Davidov, E
    Oresic, M
    Plasterer, TN
    Lavine, G
    Londo, T
    Meys, M
    Snell, P
    Stochaj, W
    Adourian, A
    Zhang, X
    Morel, N
    Neumann, E
    Verheij, E
    Vogels, JTWE
    Havekes, LM
    Afeyan, N
    Regnier, F
    Van Der Greef, J
    Naylor, S
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2004, 8 (01) : 3 - 13
  • [9] Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice
    Trion, A
    de Maat, M
    Jukema, W
    Maas, A
    Offerman, E
    Havekes, L
    Szalai, A
    van der Laarse, A
    Princen, H
    Emeis, J
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (01) : 89 - 95
  • [10] Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice
    Delsing, DJM
    Jukema, JW
    van de Wiel, MA
    Emeis, JJ
    van der Laarse, A
    Havekes, LM
    Princen, HMG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (01) : 63 - 70
12345